Sign Up to like & get
recommendations!
0
Published in 2019 at "Clinical Pharmacology in Drug Development"
DOI: 10.1002/cpdd.702
Abstract: Treatment of individuals coinfected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) requires careful consideration of potential drug‐drug interactions. The pharmacokinetic interaction of the HCV fixed‐dose combination treatment of elbasvir/grazoprevir (EBR/GZR) when coadministered…
read more here.
Keywords:
cob tdf;
tdf ftc;
ebr gzr;
evg cob ... See more keywords